Quarterly Financial Data |
The following table sets forth unaudited consolidated statements of income data for the eight quarters in the period ended December 31, 2012. This information has been derived from Acacia’s unaudited condensed consolidated financial statements that have been prepared on the same basis as the audited consolidated financial statements and, in the opinion of management, include all adjustments, consisting of normal recurring adjustments, necessary for a fair statement of the information when read in conjunction with the audited consolidated financial statements and related notes thereto. Acacia’s quarterly results have been, and may in the future be, subject to significant fluctuations. As a result, Acacia believes that results of operations for interim periods should not be relied upon as any indication of the results to be expected in any future periods. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Quarter Ended | | | Mar. 31, | | Jun. 30, | | Sept. 30, | | Dec. 31, | | Mar. 31, | | Jun. 30, | | Sept. 30, | | Dec. 31, | | | 2012 | | 2012 | | 2012 | | 2012 | | 2011 | | 2011 | | 2011 | | 2011 | | | (Unaudited, In thousands, except share and per share information) | Revenues | | $ | 99,040 |
| | $ | 50,484 |
| | $ | 34,939 |
| | $ | 66,264 |
| | $ | 61,130 |
| | $ | 39,746 |
| | $ | 50,585 |
| | $ | 20,795 |
| Operating costs and expenses: | | |
| | |
| | |
| | | | |
| | |
| | |
| | | Cost of revenues: | | |
| | |
| | |
| | | | |
| | |
| | |
| | | Inventor royalties | | 7,594 |
| | 9,573 |
| | 5,032 |
| | 3,829 |
| | 13,089 |
| | 8,588 |
| | 15,592 |
| | 6,458 |
| Contingent legal fees | | 3,748 |
| | 6,607 |
| | 8,833 |
| | 5,463 |
| | 9,367 |
| | 13,039 |
| | 12,328 |
| | 5,547 |
| Litigation and licensing expenses - patents | | 3,381 |
| | 5,268 |
| | 5,973 |
| | 6,969 |
| | 3,538 |
| | 3,761 |
| | 3,501 |
| | 2,205 |
| Amortization of patents | | 5,126 |
| | 5,393 |
| | 10,412 |
| | 18,088 |
| | 3,772 |
| | 2,600 |
| | 1,946 |
| | 1,427 |
| Verdict insurance proceeds | | — |
| | — |
| | — |
| | — |
| | — |
| | — |
| | (12,451 | ) | | — |
| Verdict insurance proceeds related costs | | — |
| | — |
| | — |
| | — |
| | — |
| | — |
| | 7,661 |
| | — |
| Marketing, general and administrative expenses (including non-cash stock compensation expense) | | 13,731 |
| | 11,903 |
| | 11,914 |
| | 16,535 |
| | 9,981 |
| | 8,302 |
| | 8,748 |
| | 8,662 |
| Research, consulting and other expenses - business development | | 1,116 |
| | 1,967 |
| | 1,139 |
| | 721 |
| | 708 |
| | 1,335 |
| | 850 |
| | 1,445 |
| Total operating costs and expenses | | 34,696 |
| | 40,711 |
| | 43,303 |
| | 51,605 |
| | 40,455 |
| | 37,625 |
| | 38,175 |
| | 25,744 |
| Operating income (loss) | | 64,344 |
| | 9,773 |
| | (8,364 | ) | | 14,659 |
| | 20,675 |
| | 2,121 |
| | 12,410 |
| | (4,949 | ) | Total other income (expense) | | 56 |
| | 102 |
| | (41 | ) | | 820 |
| | 29 |
| | 24 |
| | 25 |
| | 18 |
| Income (loss) before provision for (benefit from) income taxes | | 64,400 |
| | 9,875 |
| | (8,405 | ) | | 15,479 |
| | 20,704 |
| | 2,145 |
| | 12,435 |
| | (4,931 | ) | (Provision for) benefit from income taxes | | (14,747 | ) | | (3,494 | ) | | 1,938 |
| | (5,757 | ) | | (7,148 | ) | | (306 | ) | | (1,889 | ) | | 635 |
| Net income (loss) including noncontrolling interests | | 49,653 |
| | 6,381 |
| | (6,467 | ) | | 9,722 |
| | 13,556 |
| | 1,839 |
| | 10,546 |
| | (4,296 | ) | Net (income) loss attributable to noncontrolling interests | | 275 |
| | (60 | ) | | (152 | ) | | 101 |
| | (1,203 | ) | | 300 |
| | 257 |
| | 107 |
| Net income (loss) attributable to Acacia Research Corporation | | $ | 49,928 |
| | $ | 6,321 |
| | $ | (6,619 | ) | | $ | 9,823 |
| | $ | 12,353 |
| | $ | 2,139 |
| | $ | 10,803 |
| | $ | (4,189 | ) | Net income (loss) per common share attributable to Acacia Research Corporation: | | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| Basic income (loss) per share | | $ | 1.13 |
| | $ | 0.13 |
| | $ | (0.14 | ) | | $ | 0.20 |
| | $ | 0.35 |
| | $ | 0.05 |
| | $ | 0.26 |
| | $ | (0.10 | ) | Diluted income (loss) per share | | $ | 1.09 |
| | $ | 0.13 |
| | $ | (0.14 | ) | | $ | 0.20 |
| | $ | 0.34 |
| | $ | 0.05 |
| | $ | 0.25 |
| | $ | (0.10 | ) | Weighted-average number of shares outstanding, basic | | 44,367,499 |
| | 47,944,193 |
| | 48,332,878 |
| | 48,335,865 |
| | 35,182,811 |
| | 40,994,082 |
| | 41,292,819 |
| | 41,418,470 |
| Weighted-average number of shares outstanding, diluted | | 45,771,228 |
| | 48,938,766 |
| | 48,332,878 |
| | 48,797,304 |
| | 36,448,005 |
| | 42,453,782 |
| | 42,857,880 |
| | 41,418,470 |
|
|